CFR report identifies Chinese biopharmaceutical expansion as U.S. national security risk

A Council on Foreign Relations report argues that China's strategic efforts to dominate the biopharmaceutical value chain threaten U.S. technological leadership. The analysis highlights systemic dependencies in medical supply chains, though the extent of immediate policy shifts remains uncertain.